Erdal Safak1,2, Lars Eckardt3, Werner Jung4, Hüseyin Ince1,2, Jochen Senges5, Matthias Hochadel5, Christian Perings6, Stefan Spitzer7, Johannes Brachmann8, Karlheinz Seidl9, Hans Ulrich Hink10, Giuseppe D'Ancona11,12. 1. Vivantes Klinikum Am Urban, Diffenbach strasse, Berlin, Germany. 2. Rostock University Medical Center, Rostock, Germany. 3. Klinik für Kardiologie II - Rhythmologie, Universitätsklinikum Münster, Münster, Germany. 4. Klinik für Innere Medizin III Kardiologie, Schwarzwald-Baar Klinikum, Villingen-Schwenningen, Germany. 5. Stiftung Institut für Herzinfarktforschung, Ludwigshafen, Germany. 6. Katholisches Klinikum Lünen, Lünen, Germany. 7. Praxisklinik Herz und Gefäße Dresden and Institute of Medical Technology, Brandenburg University of Technology Cottbus, Cottbus, Germany. 8. Klinikum Coburg, Coburg, Germany. 9. Klinikum Ingolstadt, Ingolstadt, Germany. 10. Klinikum Frankfurt Höchst, Frankfurt, Germany. 11. Vivantes Klinikum Am Urban, Diffenbach strasse, Berlin, Germany. rgea@hotmail.com. 12. Rostock University Medical Center, Rostock, Germany. rgea@hotmail.com.
Abstract
BACKGROUND: In the present study, we have focused upon rates and clinical determinants of inappropriate shock (IS) after implantable cardioverter-defibrillator (ICD). METHODS: Data were collected prospectively in the German Device II Registry. RESULTS: A total of 783 patients were included. Three sub-groups were identified: non-shock (NS) included 725 patients (92.6%), IS 24 (3.1%), and appropriate shock (AS) 34 (4.3%). IS patients were younger (AS 68 (58-77); IS 59 (51-68); NS 66 (56-75) years; p = 0.03), had been mainly referred for primary prophylaxis (AS 42.4%; IS 70.8%; NS 67.3%; p = 0.01), had a higher resting heart rate (AS 70 (63-80); IS 80 (71-98); NS 70 (60-81) BPM; p = 0.003), had more often atrial fibrillation (AF) (AS 14.7%; IS 45.8%; NS 18.8%; p = 0.006), and shorter QRS duration (AS 100 (90-120); IS 95 (90-100); NS 120 (98-150) msec.; p = 0.001). VVI-ICD was more common in IS (AS 64.7%; IS 83.3%; NS 49.8%; p = 0.002). At a follow-up of 18.2 months (75% IQR 13.6-22.4), no deaths were observed in the IS group, one (2.9%) in the AS, and 36 (4.9%) in the NS (p = 0.9). At logistic regression, VVI-ICD implantation was the strongest IS independent determinant (OR 5.0; 95% CI 1.6-15.9; p = 0.004) together with age < 70 years (OR 4.6; CI 1.4-14.7; p = 0.009), AF at time of ICD implantation (OR 3.5; CI 1.3-9.1; p = 0.01), and resting heart rate > 70/min (OR 2.8; CI 1.0-7.3; p = 0.03). CONCLUSION: In a contemporary setting, some specific conditions such as VVI-ICD, younger age, and faster resting heart rates remain important IS determinants after ICD implantation.
BACKGROUND: In the present study, we have focused upon rates and clinical determinants of inappropriate shock (IS) after implantable cardioverter-defibrillator (ICD). METHODS: Data were collected prospectively in the German Device II Registry. RESULTS: A total of 783 patients were included. Three sub-groups were identified: non-shock (NS) included 725 patients (92.6%), IS 24 (3.1%), and appropriate shock (AS) 34 (4.3%). IS patients were younger (AS 68 (58-77); IS 59 (51-68); NS 66 (56-75) years; p = 0.03), had been mainly referred for primary prophylaxis (AS 42.4%; IS 70.8%; NS 67.3%; p = 0.01), had a higher resting heart rate (AS 70 (63-80); IS 80 (71-98); NS 70 (60-81) BPM; p = 0.003), had more often atrial fibrillation (AF) (AS 14.7%; IS 45.8%; NS 18.8%; p = 0.006), and shorter QRS duration (AS 100 (90-120); IS 95 (90-100); NS 120 (98-150) msec.; p = 0.001). VVI-ICD was more common in IS (AS 64.7%; IS 83.3%; NS 49.8%; p = 0.002). At a follow-up of 18.2 months (75% IQR 13.6-22.4), no deaths were observed in the IS group, one (2.9%) in the AS, and 36 (4.9%) in the NS (p = 0.9). At logistic regression, VVI-ICD implantation was the strongest IS independent determinant (OR 5.0; 95% CI 1.6-15.9; p = 0.004) together with age < 70 years (OR 4.6; CI 1.4-14.7; p = 0.009), AF at time of ICD implantation (OR 3.5; CI 1.3-9.1; p = 0.01), and resting heart rate > 70/min (OR 2.8; CI 1.0-7.3; p = 0.03). CONCLUSION: In a contemporary setting, some specific conditions such asVVI-ICD, younger age, and faster resting heart rates remain important IS determinants after ICD implantation.
Authors: Johannes B van Rees; C Jan Willem Borleffs; Mihály K de Bie; Theo Stijnen; Lieselot van Erven; Jeroen J Bax; Martin J Schalij Journal: J Am Coll Cardiol Date: 2011-02-01 Impact factor: 24.094
Authors: Michael R Bristow; Leslie A Saxon; John Boehmer; Steven Krueger; David A Kass; Teresa De Marco; Peter Carson; Lorenzo DiCarlo; David DeMets; Bill G White; Dale W DeVries; Arthur M Feldman Journal: N Engl J Med Date: 2004-05-20 Impact factor: 91.245
Authors: Paul A Friedman; Robyn L McClelland; William R Bamlet; Helbert Acosta; David Kessler; Thomas M Munger; Neal G Kavesh; Mark Wood; Emile Daoud; Ali Massumi; Claudio Schuger; Stephen Shorofsky; Bruce Wilkoff; Michael Glikson Journal: Circulation Date: 2006-06-12 Impact factor: 29.690
Authors: Dietmar Bänsch; Matthias Antz; Sigrid Boczor; Marius Volkmer; Jürgen Tebbenjohanns; Karlheinz Seidl; Michael Block; Frank Gietzen; Jürgen Berger; Karl Heinz Kuck Journal: Circulation Date: 2002-03-26 Impact factor: 29.690
Authors: Gust H Bardy; Kerry L Lee; Daniel B Mark; Jeanne E Poole; Douglas L Packer; Robin Boineau; Michael Domanski; Charles Troutman; Jill Anderson; George Johnson; Steven E McNulty; Nancy Clapp-Channing; Linda D Davidson-Ray; Elizabeth S Fraulo; Daniel P Fishbein; Richard M Luceri; John H Ip Journal: N Engl J Med Date: 2005-01-20 Impact factor: 91.245
Authors: Anne-Christine Ruwald; Claudio Schuger; Arthur J Moss; Valentina Kutyifa; Brian Olshansky; Henry Greenberg; David S Cannom; N A Mark Estes; Martin H Ruwald; David T Huang; Helmut Klein; Scott McNitt; Christopher A Beck; Robert Goldstein; Mary W Brown; Josef Kautzner; Morio Shoda; David Wilber; Wojciech Zareba; James P Daubert Journal: Circ Arrhythm Electrophysiol Date: 2014-08-18
Authors: Dominic A M J Theuns; A Peter J Klootwijk; Dick M Goedhart; Luc J L M Jordaens Journal: J Am Coll Cardiol Date: 2004-12-21 Impact factor: 24.094
Authors: James P Daubert; Wojciech Zareba; David S Cannom; Scott McNitt; Spencer Z Rosero; Paul Wang; Claudio Schuger; Jonathan S Steinberg; Steven L Higgins; David J Wilber; Helmut Klein; Mark L Andrews; W Jackson Hall; Arthur J Moss Journal: J Am Coll Cardiol Date: 2008-04-08 Impact factor: 24.094
Authors: S Adam Strickberger; John D Hummel; Thomas G Bartlett; Howard I Frumin; Claudio D Schuger; Scott L Beau; Cynthia Bitar; Fred Morady Journal: J Am Coll Cardiol Date: 2003-05-21 Impact factor: 24.094
Authors: Alan Kadish; Alan Dyer; James P Daubert; Rebecca Quigg; N A Mark Estes; Kelley P Anderson; Hugh Calkins; David Hoch; Jeffrey Goldberger; Alaa Shalaby; William E Sanders; Andi Schaechter; Joseph H Levine Journal: N Engl J Med Date: 2004-05-20 Impact factor: 91.245